Will Cozean

Bain Capital is an alternative investment firm specializing in private equity, venture capital, and credit products.

Kailera Therapeutics is a clinical-stage biotechnology company that provides therapies for treating obesity and related diseases.

Raised $400,000,000.00 from Atlas Venture, Bain Capital Life Sciences, Lyra Capital and RTW Investments.

Serán Bioscience is a contract development and manufacturing organization.

Raised $200,000,000.00 from Bain Capital Life Sciences and Vivo Capital.

Areteia Therapeutics is a biotechnology company committed to putting asthma patients in better control of their disease.

Raised $425,000,000.00 from Marshall Wace, ARCH Venture Partners, Bain Capital Life Sciences, Maverick Capital, Google Ventures, Viking Global Investors, Access Biotechnology, Sanofi, Population Health Partners and Saturn Partners.

Cardurion is a cardiovascular biotechnology company developing therapeutics for the treatment of heart failure and cardiovascular diseases.

Raised $603,150,000.00 from Delos Capital, Millennium Management, Bain Capital Private Equity, Ascenta Capital, Fidelity, Bain Capital Life Sciences, New Enterprise Associates, Blue Owl, Digitalis Ventures and Farallon Capital Management.

Cerevel Therapeutics is a biopharmaceutical company that develops drugs to treat neurological and neuropsychiatric disorders.

Raised $1,895,000,000.00 from Novaquest Capital Management, Bain Capital, T. Rowe Price, Perceptive Advisors, Boxer Capital, Surveyor Capital, Adage Capital Management, Ally Bridge Group, RA Capital Management and Sphera Global Healthcare Fund.

McKinsey Growth Tech serves leading growth stage tech players, venture capital, and growth private equity